Table 3 Influence of long-term pre- and/or probiotic administration on faecal β-glucuronidase and β-glucosidase enzyme activity (mg product formed/g faeces/h), total FO and FDW in groups 1, 2 and 3

From: Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities

  Enzyme Baseline Treatment a
    Period 1 Period 2 Period 3
Group 1 β-Glucuronidase 0.84±0.32 0.47±0.28b 0.73±0.20 0.77±0.28
  β-Glucosidase 0.97±0.65 0.98±0.48 0.85±0.46 0.89±0.62
  FDW (%) 26.62±6.12 25.37±9.20 25.96±7.44 22.39±6.90
  FO (g/72 h) 234±98 196±79 241±119 199±67
Group 2 β-Glucuronidase 0.61±0.31 0.45±0.20 0.56±0.25 0.59±0.33
  β-Glucosidase 0.99±0.78 0.99±0.87 1.12±0.79 0.88±0.49
  FDW (%) 24.60±4.52 21.90±6.71 25.64±3.16 23.58±5.42
  FO (g/72 h) 387±138 387±138 305±87 381±233
Group 3 β-Glucuronidase 0.63±0.16 0.53±0.31 0.49±0.39 0.65±0.22
  β-Glucosidase 1.23±0.64 1.15±0.78 0.93±0.54 1.03±0.60
  FDW (%) 22.78±4.56 22.69±6.24 20.36±4.93 23.39±5.34
  FO (g/72 h) 334±137 377±107 337±177 291±170
  1. Abbreviations: FDW, faecal dry weight; FO, faecal output; s.d., standard deviation.
  2. Mean±s.d., Wilcoxon test, α=0.05.
  3. aGroups 1 and 2: period 1: prebiotic lactulose; period 2: placebo; period 3: probiotic S. boulardii. Group 3: period 1: prebiotic lactulose; period 2: synbiotic lactulose+S. boulardii; period 3: probiotic S. boulardii.
  4. bSignificantly different from baseline: P=0.007.